%) Issued and fully paid-up common share (Million Share) 517.82 517.82 0.00 0.00% Par (Baht) 0.50 0.50 0.00 0.00% Management's Discussion and Analysis and operating results for the Quarter 1’ 2018 Page 5 / 6

Distribution of Newly Issued Shares and Share Warrants by Issuer

(Baht per Share) * 0.60 0.45 0.15 33.33 Weighted Average Number of Ordinary Shares (Million Shares) * 947.96 947.96 - - Return on Equity (ROE) (%) 26.37% 20.78% 5.59% Return on Assets (ROA) (%) 17.67

355.73 26.76 313.98 26.34 41.75 13.30 EBITDA 324.52 24.52 235.97 19.79 88.55 37.53 EBIT 266.63 20.06 176.36 14.79 90.27 51.19 NP 211.93 15.94 140.00 11.74 71.93 51.38 EPS (Baht per Share) * 0.22 0.15 0.07

Healthcare Center Co.,, Ltd. - a subsidiary of the Company and Wuttisak Clinic Inter Group Co., Ltd. – an indirect subsidiary of E FOR L Aim Public Co., Ltd. had been complete; and further progress shall be

Healthcare and Esthetics under Trademark “Wuttisak”, of which details appeared on the above-mentioned letters; and any further progress shall be informed to SET appropriately. In this regard, the Company would

; and (b) reports on the asset value, unit value and progress of the development of the principal assets shall be in accordance with Part 3. (3) cessation of duties under this Notification shall be in

will monitor the progress of the ongoing legal proceedings and collaborate fully with relevant agencies in subsequent processes after the filing of the criminal complaint to support law enforcement

inquiry officer, the decision to prosecute by public prosecutors, and ultimately the judicial discretion of the court in rendering a verdict. In this regard, the SEC will monitor the progress of the ongoing

discretion of the court in rendering a verdict. In this regard, the SEC will monitor the progress of the ongoing legal proceedings and collaborate fully with relevant authorities in subsequent processes